Skip to content
DefDex

Federal award

DIASORIN INC

W91YTZ20P0297

Contract

Obligated and Ceiling

Obligated (net)
$818,942.80
Ceiling (potential value, not spending)
$929,972.00
Current value
$929,972.00
Gross positive obligations
$1,034,714.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DIASORIN INC · FGK2QR959BV5
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
DIASORIN S.P.A. · KN6PH2K51SJ6
Awarding agency
Department of War · sub-agency 2100 · office W91YTZ
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W91YTZ20P0297
Award type code
B
Actions
14 · Sep 23, 2020 to Jul 15, 2025
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History14

Award actions
DateFYModAction typeObligationCompany in company totals
Jul 15, 2025FY2025P00013C−$111,029.20
—
Apr 9, 2025FY2025P00012C−$55,790.00
—
Nov 12, 2024FY2025P00011C$208,197.00
—
Sep 16, 2024FY2024P00010G$0.00
—
Aug 2, 2024FY2024P00009C−$48,952.00
—
Jul 23, 2024FY2024P00008C$2,520.00
—
Dec 15, 2023FY2024P00007C$205,997.00
—
Jul 13, 2023FY2023P00006G$0.00
—
Oct 27, 2022FY2023P00005C$206,000.00
—
Jun 3, 2022FY2022P00004G$0.00
—
Oct 6, 2021FY2022P00003C$206,000.00
—
Aug 18, 2021FY2021P00002G$0.00
—
Nov 12, 2020FY2021P00001C$206,000.00
—
Sep 23, 2020FY20200—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.